Oxidation-State-Dependent Binding Properties of the Active Site in a Mo-Containing Formate Dehydrogenase.

TitleOxidation-State-Dependent Binding Properties of the Active Site in a Mo-Containing Formate Dehydrogenase.
Publication TypeJournal Article
Year of Publication2017
AuthorsRobinson, WE, Bassegoda, A, Reisner, E, Hirst, J
JournalJ Am Chem Soc
Volume139
Issue29
Pagination9927-9936
Date Published2017 Jul 26
ISSN1520-5126
Abstract

Molybdenum-containing formate dehydrogenase H from Escherichia coli (EcFDH-H) is a powerful model system for studies of the reversible reduction of CO2 to formate. However, the mechanism of FDH catalysis is currently under debate, and whether the primary Mo coordination sphere remains saturated or one of the ligands dissociates to allow direct substrate binding during turnover is disputed. Herein, we describe how oxidation-state-dependent changes at the active site alter its inhibitor binding properties. Using protein film electrochemistry, we show that formate oxidation by EcFDH-H is inhibited strongly and competitively by N3(-), OCN(-), SCN(-), NO2(-), and NO3(-), whereas CO2 reduction is inhibited only weakly and not competitively. During catalysis, the Mo center cycles between the formal Mo(VI)═S and Mo(IV)-SH states, and by modeling chronoamperometry data recorded at different potentials and substrate and inhibitor concentrations, we demonstrate that both formate oxidation and CO2 reduction are inhibited by selective inhibitor binding to the Mo(VI)═S state. The strong dependence of inhibitor-binding affinity on both Mo oxidation state and inhibitor electron-donor strength indicates that inhibitors (and substrates) bind directly to the Mo center. We propose that inhibitors bind to the Mo following dissociation of a selenocysteine ligand to create a vacant coordination site for catalysis and close by considering the implications of our data for the mechanisms of formate oxidation and CO2 reduction.

DOI10.1021/jacs.7b03958
Alternate JournalJ. Am. Chem. Soc.
Citation Key10.1021/jacs.7b03958
PubMed ID28635274
PubMed Central IDPMC5532686